Category Archives: Appeal

DC dismissal of IPR institution decision action affirmed, reversed as to Apple’s improper USPTO rule-making argument

Apple, Inc., et al. (Cisco, Google, Edwards LifeSciences (“Apple”)) v. USPTO Docket No. 2022-1249 (https://cafc.uscourts.gov/opinions-orders/22-1249.OPINION.3-13-2023_2093598.pdf) LOURIE, TARANTO, STOLL March 13, 2023 Brief Summary:   DC decision dismissing its action against the USPTO regarding its IPR institution decision affirmed, but reversed … Continue reading

Posted in Appeal, Article III disputes, Inter Parties Review (IPR), IPR | Leave a comment

CyWee’s Arthrex-like arguments rejected; Board extension of time to produce FWDs and USPTO Director denial of rehearing affirmed

Cywee Group Ltd. v. Google LLC et al. (USPTO as Intervenor) Docket No. 2020-1565, -1567 (IPR2018-01257-8 (https://cafc.uscourts.gov/opinions-orders/20-1565.OPINION.2-8-2023_2077658.pdf) PROST, TARANTO, CHEN February 8, 2023 Brief Summary:   CyWee’s Arthrex-like arguments rejected; Board extension of time to produce FWDs and USPTO Director … Continue reading

Posted in Appeal, Inter Parties Review (IPR), IPR | Leave a comment

Novartis appeals to SCOTUS rehearing of FC panel decision reversing negative limitation written description finding of prior FC panel

Novartis Pharm. Corp. v. Accord Healthcare, et al. and HEC Pharm Co., Ltd. et al. Docket No. 2021-1070 (https://cafc.uscourts.gov/opinions-orders/21-1070.OPINION.1-3-2022_1887614.pdf) MOORE (D), LINN, O’MALLEY January 24, 2022 Second Update (January 24, 2023): Novartis petitioned SCOTUS with two questions presented:  1) Whether … Continue reading

Posted in Appeal, Negative Limitations, U.S. Supreme Court, Written description | Leave a comment

FC panel affirms Board IPR decisions finding P Tech’s robotic surgical instrument claims obvious

P Tech, LLC v. Intuitive Surgical, Inc. Docket No. 2022-1102, -1115 (IPR-2020-00649-50) (https://cafc.uscourts.gov/opinions-orders/22-1102.OPINION.12-15-2022_2048477.pdf) (Non-Precedential) LOURIE, DYK, CUNNINGHAM December 15, 2022 Brief Summary:   Board IPR decisions of obviousness of P Tech’s robotic surgical instrument claims affirmed. Summary:  P Tech appealed … Continue reading

Posted in Appeal, Claim Construction, Inter Parties Review (IPR), IPR, Obviousness | Leave a comment

Board denial of IPR dismissal after Arthrex II, claim construction, and invalidity decisions affirmed

Polaris Innovations Limited v. USPTO Docket No. 2019-1483 (IPR2017-01500), 2019-1484 (IPR2017-00901) (https://cafc.uscourts.gov/opinions-orders/19-1483.OPINION.9-15-2022_2004261.pdf) PROST, CHEN, STOLL September 15, 2022 Brief Summary:   Board denial of join request to dismiss IPRs following Arthrex II, claim construction (BRC as pre-Nov. 23, 2018), and … Continue reading

Posted in Appeal, Claim Construction, Claim Differentiation, Expert Testimony, Inter Parties Review (IPR), IPR, Obviousness | Leave a comment

Board IPR obviousness decisions affirmed, appeal regarding canceled claim dismissed

Best Medical Int., Inc. v. Elekta Inc. Docket No. 2021-2099, -2100 (IPR2020-0070-72) (https://cafc.uscourts.gov/opinions-orders/21-2099.OPINION.8-26-2022_1996028.pdf) HUGHES, LINN, STOLL August 26, 2022 Brief Summary:   Board IPR obviousness decisions affirmed, appeal regarding canceled claim dismissed. Summary:  BMI appealed two IPR Board decisions finding … Continue reading

Posted in Appeal, Article III disputes, Inter Parties Review (IPR), IPR, Obviousness | Leave a comment

DC correctly construed claims (e.g., “and” means “and/or”) but improperly denied pre-judgment interest

Micheal Philip Kaufman v. Microsoft Corporation Docket No. 2021-1634, -1691 (https://cafc.uscourts.gov/opinions-orders/21-1634.OPINION.5-20-2022_1954422.pdf) DYK, TARANTO, CUNNINGHAM May 20, 2022 Brief Summary:   DC claim construction affirmed but denial of pre-judgment interest reversed. Summary:  Mr. Kaufman appealed the DC’s denial of his motion … Continue reading

Posted in Appeal, Claim Construction, Damages, Lost Profits, Preamble, Royalties | Leave a comment

DC finding of no Article III case or controversy remanded; transfer from CA to TX affirmed

Mitek Systems, Inc. v. United Services Automobile Association Docket No. 2021-1989 (https://cafc.uscourts.gov/opinions-orders/21-1989.OPINION.5-20-2022_1954430.pdf) DYK, TARANTO, CUNNINGHAM May 20, 2022 Brief Summary:   DC finding of no Article III case or controversy remanded; transfer from CA to TX affirmed. Summary:  Mitek’s originally … Continue reading

Posted in Appeal, Article III disputes, Jurisdiction | Leave a comment

Termination of IPR outside of FC jurisdiction, including regarding sanctions

Atlanta Gas Light Company v. Bennett Regulator Guards, Inc. Docket No. 2021-1759 (IPR2015-00826) (https://cafc.uscourts.gov/opinions-orders/21-1759.OPINION.5-13-2022_1951471.pdf) NEWMAN, LOURIE, STOLL May 13, 2022 Brief Summary:   Appeal dismissed as FC lacked jurisdiction over IPR termination. Summary:  Atlanta Gas appealed USPTO IPR decision termination … Continue reading

Posted in Appeal, Inter Parties Review (IPR), IPR | Leave a comment

DC grant of SJ for indefiniteness and obviousness of Immunogen’s claims vacated and remanded

Immunogen, Inc. v. USPTO Docket No. 2021-1939 (https://cafc.uscourts.gov/opinions-orders/21-1939.OPINION.3-25-2022_1926731.pdf) (Non-precedential) NEWMAN, CLEVENGER, STOLL March 25, 2022 Brief Summary:   DC grant of SJ that Immunogen’s pending claims are indefinite and obvious vacated and remanded as factual findings not undisputed. Summary:  Immunogen … Continue reading

Posted in Appeal, Incorporation by Reference, Indefiniteness, Obviousness, Written description | Leave a comment